Aviva
KRYS icon

Aviva’s Krystal Biotech KRYS Stock Holding History

Aviva’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$437K Sell
1,691
-537
-24% -$143K ﹤0.01% 752
2025
Q4 		$549K Sell
2,228
-1,003
-31% -$211K ﹤0.01% 710
2025
Q3 		$570K Sell
3,231
-344
-10% -$51.5K ﹤0.01% 681
2025
Q2 		$491K Buy
3,575
+319
+10% +$46.9K ﹤0.01% 746
2025
Q1 		$587K Buy
+3,256
New +$548K ﹤0.01% 728
2021
Q2 		– Sell
-17,198
Closed -$1.32M – 923
2021
Q1 		$1.32M Sell
17,198
-11,896
-41% -$865K 0.01% 745
2020
Q4 		$1.75M Sell
29,094
-23,584
-45% -$1.18M 0.01% 709
2020
Q3 		$2.27M Sell
52,678
-2,621
-5% -$114K 0.01% 714
2020
Q2 		$2.29M Sell
55,299
-37,644
-41% -$1.81M 0.01% 704
2020
Q1 		$4.02M Buy
+92,943
New +$4.86M 0.03% 461

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return